T-cell and dendritic cell function and the effects of combination therapy in hepatitis C virus infection
Hepatitis C Virus infects 170 million people worldwide. Following primary infection approximately 15% of individuals resolve infection spontaneously whilst the remainder develop persistent infection. Combination therapy (interferon-alpha and ribavirin) is now the mainstay of treatment and, depending...
Main Author: | |
---|---|
Published: |
University College London (University of London)
2004
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.409337 |